研究单位:[1]Chengdu Kanghong Biotech Co., Ltd.[2]Beijing Hospital,Beijing,China[3]Beijing Shijitan Hoospital.Cmu,Beijing,China[4]Beijing Tongren Hospital,Cmu,Beijing,China[5]Chinese Pla General Hospital,Beijing,China[6]Peking Union Medical College Hospital,Beijing,China[7]Peking University First Hospital,Beijing,China[8]Peking University People'S Hospital,Beijing,China[9]PEKING UNIVERSITY Third HOSPITAL,Beijing,China[10]The Scond Xiangya Hospital of Central South University,Changsha,China[11]Xiangya Hospital Central South University,Changsha,China[12]General Hospial og Guangzhou Military Command of PLA,Guangzhou,China[13]ZhongShan Ophthalmic Center,Sun Yat-sen University,Guangzhou,China[14]Hainan Eye Hospital of Zhongshan Ophthalmic Center, Sun Yat-sen University,Hainan,China[15]Hebei Eye Hospital,Hebei,China[16]The Second Hospital of Hebei Medical University,Hebei,China[17]Henan Province People's Hospital,Henan,China[18]The Second Hospital of Jilin University,Jilin,China[19]Lanzhou University Second Hospital,Lanzhou,China[20]Affiliated Eye Hospital of Nanchang University,Nanchang,China[21]The First Affiliated Hospital of Nanchang University,Nanchang,China[22]Nanjing General Hospital,Nanjing,China[23]The First Affiliated Hospital With Nanjing Medical University,Nanjing,China[24]Ningxia Peple'S Hospital,Ningxia,China[25]Eye&Ent Hospital of Fudan University,Shanghai,China[26]Renji Hospital Shanghai Jiaotong University School of Medicine,Shanghai,China[27]Shanghai General Hospital,Shanghai,China[28]Stu/Cuhk Joint Shantou International Eye Center,Shantou,China[29]Shanxi Eye Hospital,Shanxi,China[30]Shenzhen Eye Hospital,Shenzhen,China[31]Tianjin Medical University Eye Hospital,Tianjin,China[32]The Eye Hospital of Wmu Zhejiang Eye Hospital,Wenzhou,China[33]Renmin Hospital of Wuhan University,Wuhan,China[34]The Chinese people's liberation army 474 hospital,Wulumuqi,China[35]Xiamen Eye Centre of Xiamen University,Xiamen,China[36]The Second Affiliated Hospital Zhejiang University School of Medicine,Zhejiang,China
研究目的:
To assess the efficacy of intravitreal injection of 0.5 mg conbercept in patients with polypoidal choroidal vasculopathy (PCV) and explore the optimal route of administration.